Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (301-310 of 669) with videos related to

Pageof 67
Sort By:
Chemical Communications (Cambridge, England)|March 15, 2019
An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanismsLeli Zeng, Jia Li, Chen Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 8, 2026
Redox-Regulated Phase Switchable Peptide Droplets with Degradation Resistance for Intravenous Delivery of BiopharmaceuticalsRan Chen, Yanan Jiang, Mingchen Lv, et al.
Frontiers in Pharmacology|June 30, 2025
Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)Haigan Yang, Zheshen Li, Zhuoxun Wu, et al.
Frontiers in Pharmacology|May 17, 2024
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cellsXuan-Yu Chen, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Medcomm|January 3, 2022
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cellsZi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, et al.
Frontiers in Immunology|October 20, 2022
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the worldVivek P Chavda, Qian Yao, Lalitkumar K Vora, et al.
Recent Patents on Anti-Cancer Drug Discovery|September 1, 2022
The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular CarcinomaRuixiang Guo, Huiru Dai, Fuweijian Liu, et al.
Biochemical Pharmacology|January 1, 2015
Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)Brian B Hasinoff, Xing Wu, Arun A Yadav, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 17, 2022
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and ImplicationsQiurong Yang, Jing Xu, Jianmei Gu, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 30, 2022
The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer ModelXing-Guo Tang, Ke Lin, Shun-Wen Guo, et al.
Pageof 67

Showing results (301-310 of 669) with videos related to

Sort By:
Pageof 67
Chemical Communications (Cambridge, England)|March 15, 2019
An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanismsLeli Zeng, Jia Li, Chen Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 8, 2026
Redox-Regulated Phase Switchable Peptide Droplets with Degradation Resistance for Intravenous Delivery of BiopharmaceuticalsRan Chen, Yanan Jiang, Mingchen Lv, et al.
Frontiers in Pharmacology|June 30, 2025
Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)Haigan Yang, Zheshen Li, Zhuoxun Wu, et al.
Frontiers in Pharmacology|May 17, 2024
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cellsXuan-Yu Chen, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Medcomm|January 3, 2022
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cellsZi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, et al.
Frontiers in Immunology|October 20, 2022
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the worldVivek P Chavda, Qian Yao, Lalitkumar K Vora, et al.
Recent Patents on Anti-Cancer Drug Discovery|September 1, 2022
The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular CarcinomaRuixiang Guo, Huiru Dai, Fuweijian Liu, et al.
Biochemical Pharmacology|January 1, 2015
Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)Brian B Hasinoff, Xing Wu, Arun A Yadav, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 17, 2022
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and ImplicationsQiurong Yang, Jing Xu, Jianmei Gu, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 30, 2022
The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer ModelXing-Guo Tang, Ke Lin, Shun-Wen Guo, et al.
Pageof 67